To the Editor.—
An article in the November 14, 1990, issue of JAMA, "The Federal Regulation of Prescription Drug Advertising and Promotion,"1 was most informative. There was, however, conspicuous failure to address a key question: does the Food and Drug Administration (FDA) consider how much advertising and promotion add to the escalating cost of drugs? An answer to this question is particularly appropriate at this time when there is a public mandate for legislation to control the high cost of medical care.
Joseph HL. The FDA and Drug Marketing Expenditures. JAMA. 1991;265(12):1528. doi:10.1001/jama.1991.03460120042027